Teladoc Health (TDOC) Shares Outstanding (2013 - 2026)

Teladoc Health has disclosed Shares Outstanding across 14 years of filings, most recently posting $180.4 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $180.4 million, up 2.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $180.4 million (up 2.9% YoY), and the FY2025 annual result was $178.3 million, up 2.83% from the prior year.
• Shares Outstanding came in at $180.4 million for Q1 2026 at Teladoc Health, up from $178.3 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $180.4 million in Q1 2026 to a low of $161.4 million in Q1 2022.
• The 5-year median for Shares Outstanding is $169.3 million (2024), against an average of $169.6 million.
• Peak annual rise in Shares Outstanding reached 4.55% in 2022, while the deepest fall reached 1.36% in 2022.
• Teladoc Health's Shares Outstanding stood at $162.8 million in 2022, then increased by 2.34% to $166.7 million in 2023, then advanced by 4.05% to $173.4 million in 2024, then advanced by 2.83% to $178.3 million in 2025, then advanced by 1.19% to $180.4 million in 2026.
• The last three Shares Outstanding figures came in at $180.4 million (Q1 2026), $178.3 million (Q4 2025), and $177.3 million (Q3 2025), per Business Quant data.